| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC | 401 W 15TH ST STE 520 | AUSTIN | TX | 78701-1671 | TRAVIS | USA | U24FD007488 | Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making. | 000 | 2 | FDA | 11/1/2023 | $0 |
| | 2024 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC | 401 W 15TH ST STE 520 | AUSTIN | TX | 78701-1671 | TRAVIS | USA | U24FD007488 | Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making. | 001 | 2 | FDA | 11/1/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $414,246 ) |
| | 2023 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD007488 | Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making. | 002 | 2 | FDA | 8/14/2023 | $182,837 |
| | 2023 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD007488 | Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making. | 000 | 2 | FDA | 11/1/2022 | $231,409 |
| | 2023 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD007488 | Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making. | 001 | 2 | FDA | 1/17/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $230,834 ) |
| | 2022 | 2022 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD007488 | Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making. | 001 | 1 | FDA | 12/16/2021 | $0 |
| | 2022 | 2022 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD007488 | Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making. | 000 | 1 | FDA | 11/11/2021 | $230,834 |
|
| Issue Date FY: 2021 ( Subtotal = -$78,515 ) |
| | 2021 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006491 | Developing Acute Kidney Injury CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 2 | FDA | 4/2/2021 | -$13,409 |
| | 2021 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006493 | Developing Congestive Heart Failure CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 2 | FDA | 4/2/2021 | -$28,366 |
| | 2021 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006494 | Developing Psoriasis CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 2 | FDA | 4/2/2021 | -$24,298 |
| | 2021 | 2017 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U01FD005854 | Development of a CDISC Therapeutic Area Standard for Lung Cancer | 000 | 2 | FDA | 3/25/2021 | $0 |
| | 2021 | 2015 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | R24FD004655 | CDISC Standardization for Cardiovascular Imaging and Schizophrenia | 000 | 1 | FDA | 6/16/2021 | -$12,442 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006493 | Developing Congestive Heart Failure CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 2 | FDA | 11/18/2019 | $0 |
| | 2020 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006494 | Developing Psoriasis CDISC Clinical Data Standards for Clinical Research and Drug Development. | 001 | 2 | FDA | 8/5/2020 | $0 |
| | 2020 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006494 | Developing Psoriasis CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 2 | FDA | 11/18/2019 | $0 |
| | 2020 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006493 | Developing Congestive Heart Failure CDISC Clinical Data Standards for Clinical Research and Drug Development. | 001 | 2 | FDA | 8/5/2020 | $0 |
| | 2020 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006491 | Developing Acute Kidney Injury CDISC Clinical Data Standards for Clinical Research and Drug Development. | 001 | 2 | FDA | 8/5/2020 | $0 |
| | 2020 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006491 | Developing Acute Kidney Injury CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 2 | FDA | 11/18/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $299,031 ) |
| | 2019 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006494 | Developing Psoriasis CDISC Clinical Data Standards for Clinical Research and Drug Development. | 001 | 2 | FDA | 7/19/2019 | $99,555 |
| | 2019 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006491 | Developing Acute Kidney Injury CDISC Clinical Data Standards for Clinical Research and Drug Development. | 001 | 2 | FDA | 7/19/2019 | $99,921 |
| | 2019 | 2019 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006493 | Developing Congestive Heart Failure CDISC Clinical Data Standards for Clinical Research and Drug Development. | 001 | 2 | FDA | 7/19/2019 | $99,555 |
| | 2019 | 2018 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006494 | Developing Psoriasis CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 1 | FDA | 3/21/2019 | $0 |
| | 2019 | 2018 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006491 | Developing Acute Kidney Injury CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 1 | FDA | 3/21/2019 | $0 |
| | 2019 | 2018 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006493 | Developing Congestive Heart Failure CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 1 | FDA | 3/21/2019 | $0 |
| | 2019 | 2017 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U01FD005854 | Development of a CDISC Therapeutic Area Standard for Lung Cancer | 000 | 2 | FDA | 11/2/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $749,717 ) |
| | 2018 | 2018 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006494 | Developing Psoriasis CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 1 | FDA | 7/16/2018 | $249,996 |
| | 2018 | 2018 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006493 | Developing Congestive Heart Failure CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 1 | FDA | 7/16/2018 | $249,996 |
| | 2018 | 2018 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD006491 | Developing Acute Kidney Injury CDISC Clinical Data Standards for Clinical Research and Drug Development. | 000 | 1 | FDA | 7/16/2018 | $249,725 |
| | 2018 | 2017 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U01FD005854 | Development of a CDISC Therapeutic Area Standard for Lung Cancer | 000 | 2 | FDA | 7/18/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $236,565 ) |
| | 2017 | 2017 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD005634 | Development of CDISC Therapeutic Area Standard for Colorectal Cancer | 002 | 1 | FDA | 4/19/2017 | $50,000 |
| | 2017 | 2017 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U01FD005854 | Development of a CDISC Therapeutic Area Standard for Lung Cancer | 002 | 2 | FDA | 8/29/2017 | $50,008 |
| | 2017 | 2017 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U01FD005854 | Development of a CDISC Therapeutic Area Standard for Lung Cancer | 003 | 2 | FDA | 9/27/2017 | $136,557 |
| | 2017 | 2016 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U01FD005854 | Development of a CDISC Therapeutic Area Standard for Lung Cancer | 001 | 1 | FDA | 5/3/2017 | $0 |
| | 2017 | 2016 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U01FD005854 | Development of a CDISC Therapeutic Area Standard for Lung Cancer | 000 | 1 | FDA | 10/28/2016 | $0 |
| | 2017 | 2015 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD005634 | Development of CDISC Therapeutic Area Standard for Colorectal Cancer | 001 | 1 | FDA | 4/13/2017 | $0 |
| | 2017 | 2015 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD005634 | Development of CDISC Therapeutic Area Standard for Colorectal Cancer | 000 | 1 | FDA | 11/8/2016 | $0 |
| | 2017 | 2015 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701-1666 | TRAVIS | USA | U24FD005243 | Development of Prostate Cancer Standards | 000 | 2 | FDA | 12/13/2016 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $224,971 ) |
| | 2016 | 2016 | Clinical Data Interchange Standards Consortium | 4488 Heritage Well Lane | ROUND ROCK | TX | 78665 | WILLIAMSON | USA | U01FD005854 | Development of a CDISC Therapeutic Area Standard for Lung Cancer | 000 | 1 | FDA | 9/9/2016 | $224,971 |
| | 2016 | 2015 | Clinical Data Interchange Standards Consortium | 4488 Heritage Well Lane | ROUND ROCK | TX | 78665 | WILLIAMSON | USA | U24FD005243 | Development of Prostate Cancer Standards | 000 | 2 | FDA | 7/19/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $384,190 ) (Continued on the next page) |
| | 2015 | 2015 | Clinical Data Interchange Standards Consortium | 4488 Heritage Well Lane | ROUND ROCK | TX | 78665 | WILLIAMSON | USA | U24FD005634 | Development of CDISC Therapeutic Area Standard for Colorectal Cancer | 000 | 1 | FDA | 9/11/2015 | $223,593 |
|
